X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4049) 4049
Book Chapter (19) 19
Dissertation (3) 3
Magazine Article (3) 3
Conference Proceeding (2) 2
Book / eBook (1) 1
Book Review (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
clinical-response (2955) 2955
humans (2780) 2780
female (1495) 1495
male (1443) 1443
middle aged (1148) 1148
adult (1130) 1130
treatment outcome (902) 902
oncology (803) 803
pharmacology & pharmacy (749) 749
aged (739) 739
psychiatry (608) 608
clinical response (503) 503
therapy (464) 464
cancer (463) 463
infliximab (453) 453
care and treatment (397) 397
double-blind (393) 393
efficacy (374) 374
rheumatology (346) 346
animals (337) 337
adalimumab (326) 326
gastroenterology & hepatology (324) 324
analysis (320) 320
drug therapy (313) 313
immunology (313) 313
neurosciences (293) 293
adolescent (292) 292
antibodies, monoclonal - therapeutic use (289) 289
immunotherapy (288) 288
clinical neurology (283) 283
research (277) 277
schizophrenia (275) 275
chemotherapy (266) 266
tumor necrosis factor-alpha - antagonists & inhibitors (264) 264
prognosis (259) 259
young adult (251) 251
patients (244) 244
aged, 80 and over (241) 241
pharmacokinetics (241) 241
retrospective studies (239) 239
rheumatoid arthritis (221) 221
dose-response relationship, drug (217) 217
antirheumatic agents - therapeutic use (216) 216
schizophrenia - drug therapy (214) 214
rheumatoid-arthritis (213) 213
health aspects (211) 211
medicine & public health (211) 211
crohns-disease (210) 210
tumors (208) 208
prospective studies (206) 206
severity of illness index (204) 204
genetic aspects (202) 202
clinical-responses (200) 200
pharmacogenetics (199) 199
safety (194) 194
time factors (193) 193
clozapine (187) 187
mutation (184) 184
arthritis, rheumatoid - drug therapy (181) 181
etanercept (178) 178
medicine, research & experimental (178) 178
antipsychotic agents - therapeutic use (177) 177
surgery (172) 172
biomarkers (164) 164
psoriasis (164) 164
dermatology (161) 161
association (160) 160
medical research (160) 160
remission (159) 159
abridged index medicus (155) 155
inflammatory-bowel-disease (155) 155
ulcerative colitis (155) 155
clinical trials (154) 154
follow-up studies (154) 154
survival (154) 154
antineoplastic agents - therapeutic use (150) 150
complete clinical-response (150) 150
genotype (146) 146
medicine, general & internal (145) 145
inflammatory bowel disease (144) 144
child (143) 143
colorectal cancer (143) 143
expression (143) 143
maintenance therapy (139) 139
studies (137) 137
review (135) 135
immunogenicity (134) 134
metastatic melanoma (134) 134
antibodies (132) 132
hematology (132) 132
melanoma (132) 132
dendritic cells (130) 130
major depression (129) 129
trial (129) 129
clinical trials as topic (126) 126
drug therapy, combination (125) 125
arthritis (124) 124
gefitinib (124) 124
monoclonal antibodies (124) 124
predictive value of tests (123) 123
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3872) 3872
Japanese (57) 57
French (54) 54
German (37) 37
Spanish (26) 26
Chinese (20) 20
Portuguese (9) 9
Russian (8) 8
Polish (6) 6
Czech (2) 2
Hungarian (2) 2
Italian (2) 2
Danish (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal Article
Cancer Research, ISSN 0008-5472, 11/2018, Volume 78, Issue 22, pp. 6486 - 6496
Biomarkers such as programmed death receptor 1 ligand (PD-L1) expression, tumor mutational burden (TMB), and high microsatellite instability are potentially... 
CELL LUNG-CANCER | CTLA-4 BLOCKADE | REPAIR | PEMBROLIZUMAB | ONCOLOGY | IMMUNOTHERAPY | PD-1 BLOCKADE | OPEN-LABEL | ATEZOLIZUMAB | CLINICAL-RESPONSE | STAGE IV
Journal Article
Clinical cancer research, ISSN 1557-3265, 2018, Volume 24, Issue 21, pp. 5368 - 5380
Purpose: Radiotherapy (RT) can transform the immune landscape and render poorly immunogenic tumors sensitive to PD-L1 inhibition. Here, we established that the... 
HEAD | TGF-BETA | ONCOLOGY | IFN-GAMMA | ACQUIRED-RESISTANCE | ORAL-CAVITY | TREG CELLS | VERSUS-HOST-DISEASE | CLINICAL-RESPONSE | EXPRESSION | CANCER
Journal Article